3 April 2026 - The Health Minister is hopeful the country’s largest biotech firm CSL will be exempt after Australia was hit with the highest penalties on branded pharmaceuticals.

Australia’s pharmaceutical industry has demanded the Albanese Government push through reforms of its PBS after the US slapped a 100% branded medicine tariff on Australia, its highest rate under a new block of global import penalties.

Australia’s biggest biotech company CSL said it was assessing the impact of an executive order by US President Donald Trump, with early indications suggesting it would be largely exempt and face minimal impacts.

Read The Australian article